查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2082183

2026年全球蚊媒傳染病檢查市場報告

Mosquito-Borne Infections Testing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，蚊媒性行為感染檢測市場規模持續強勁成長。預計該市場規模將從2025年的14.4億美元成長至2026年的15.6億美元，年複合成長率達7.8%。成長要素包括登革熱和瘧疾疫情的增加、發展中地區先進診斷基礎設施的匱乏、人們對蚊媒疾病負擔的認知不斷提高、都市區醫療衛生系統檢測能力的提升以及政府對感染疾病防治項目的投入增加。

預計未來幾年，蚊媒傳染病檢查市場將維持強勁成長，到2030年將達到21.2億美元，複合年成長率（CAGR）為8.0%。預測期內的成長預計將受到以下因素的推動：氣候變遷導致蚊蟲棲息地和疾病傳播區域的擴大；快速分子診斷技術的日益普及；即時疫情監測和預測監測系統的廣泛應用；對綜合公共衛生數據報告系統需求的成長；以及個性化和精準感染疾病診斷技術的擴展。預測期內的主要趨勢包括：性行為感染媒疾病發病率上升導致對快速診斷檢測的需求增加；農村和偏遠地區分佈式和即時檢測的擴展；用於同時檢測多種媒介的多重檢測方法的日益普及；政府主導的監測和篩檢項目得到加強，以便及早發現疫情；以及對攜帶式和現場部署型診斷盒的需求不斷成長，以便更快地應對疫情。

登革熱發病率的上升預計將推動蚊媒傳染病檢查市場的成長。登革熱是由登革病毒引起的蚊媒病毒感染疾病，主要透過埃及斑蚊傳播。登革熱發病率上升的原因包括氣溫升高和降雨量增加，這些因素為埃及伊蚊的繁殖創造了有利條件；此外，快速的都市化也增加了人類接觸蚊子的機會。透過檢測患者體內是否有病毒，蚊媒感染疾病檢測有助於早期發現和監測登革熱。這有助於及時進行醫療干預，並支持公共衛生措施控制疾病傳播。例如，根據總部位於瑞士的政府間組織－世界衛生組織（世衛組織）的數據，截至2023年7月，巴西在流行病學週的第26週之前共記錄了2,376,52 2例登革熱病例，其中1,051,773例（44.2%）經檢測確診，1,249例（0.05%）被歸類為重症登革熱，與2022年同期相比成長了13%。因此，登革熱發病率的上升正在推動蚊媒傳染病檢查市場的成長。

國際旅行和貿易的成長預計將持續推動蚊媒傳染病檢查感染疾病的發展。國際旅行和貿易是指人員和貨物跨境流動，其目的包括旅遊、商務和國際貿易等。隨著新冠疫情限制措施的逐步放寬，國際旅行和貿易規模擴大，促進了全球旅行，並加強了跨境貨物流通。國際旅行和貿易促進了不同地區間人員和貨物的流動，這可能將蚊媒病原體引入新的地區。因此，加強對這些感染疾病的監測和檢測對於預防潛在的疫情爆發至關重要。例如，根據美國聯邦政府機構國家旅遊局（NTTO）的數據，截至2024年5月，2023年國際觀光總數為6,650萬人次，比2022年的5,080萬人次增加了1,570萬人次，凸顯了全球旅行的顯著成長。因此，國際旅行和貿易的成長正在推動蚊媒傳染病檢查市場的發展。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球蚊媒傳染病檢查市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 生物技術、基因組學和精準醫療
    • 數位化、雲端運算、巨量資料、網路安全
    • 物聯網、智慧基礎設施、互聯生態系統
    • 人工智慧和自主智慧
    • 工業4.0和智慧製造
  • 主要趨勢
    • 蚊媒性行為感染病例的增加推動了對快速診斷測試的需求。
    • 在農村和偏遠地區擴大分散式檢查和即時檢測。
    • 多重檢測技術在同時檢測多種媒介傳播病原體方面的應用日益廣泛。
    • 擴大政府主導的監測和篩檢項目，以便及早發現感染傳播
    • 對攜帶式和現場部署型診斷試劑盒的需求日益成長，以便快速應對感染疾病。

第5章 終端用戶產業市場分析

  • 醫院和診所
  • 診斷檢查室
  • 照護端環境
  • 公共衛生組織
  • 研究機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球蚊媒傳染病檢查市場：PESTEL 分析
  • 全球蚊媒傳染病檢查市場：規模、對比及成長率分析
  • 全球蚊媒傳染病檢查市場表現：規模與成長，2020-2025年
  • 全球蚊媒傳染病檢查市場預測：規模與成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 按測試類型
  • 分子診斷測試、血清學測試、快速抗原測試、聚合酵素鏈鎖反應(PCR) 測試服務以及使用診斷試劑的測試。
  • 依樣本類型
  • 血液檢體、血清檢體、血漿檢體、尿液檢體、唾液檢體
  • 按感染類型
  • 登革熱、瘧疾、茲卡病毒、屈公病、西尼羅河病毒和其他感染疾病
  • 透過技術
  • 酵素免疫分析法（ELISA）、橫向流動化驗、聚合酵素鏈鎖反應（PCR）、次世代定序及其他技術
  • 最終用戶
  • 醫院和診所、診斷檢測實驗室、公共衛生組織、研究機構、即時檢測環境
  • 按類型細分：分子診斷測試
  • 核酸增幅檢查、逆轉錄聚合酵素鏈鎖反應(RT-PCR) 檢測、多重檢測、等溫擴增檢測、病原體特異性基因檢測
  • 按類型細分：血清學檢測
  • 免疫球蛋白M抗體檢測、免疫球蛋白G抗體檢測、抗原檢測、中及試驗、酵素免疫分析法
  • 按類型細分：快速抗原檢測
  • 即時抗原檢測、側向層析抗原檢測、層析法抗原檢測、攜帶式快速診斷檢測、現場抗原檢測
  • 細分（按類型）：聚合酵素鏈鎖反應(PCR) 檢測服務
  • 即時聚合酵素鏈鎖反應（PCR）檢測、定量聚合酵素鏈鎖反應（PCR）檢測、多重聚合酵素鏈鎖反應（PCR）檢測、數位聚合酵素鏈鎖反應（PCR）檢測、逆轉錄聚合酵素鏈鎖反應（PCR）檢測
  • 按類型細分：使用診斷試劑的測試
  • 使用試劑組的診斷測試、使用化學反應的測試、使用酵素試劑的測試、使用染色試劑的測試、使用緩衝溶液的測試

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 蚊媒傳染病檢查市場：競爭格局及市場佔有率（2024年）
  • 蚊媒傳染病檢查市場：公司估值矩陣
  • 蚊媒傳染病檢查市場：公司概況
    • F. Hoffmann-La Roche Ltd
    • Trinity Biotech plc
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Laboratory Corporation of America Holdings（LabCorp）

第37章 其他大型企業和創新企業

  • Grifols SA, Hologic Inc., bioMerieux SA, Bio-Rad Laboratories Inc., QIAGEN NV, DiaSorin SpA, Euroimmun Medizinische Diagnostika AG, SD Biosensor Inc., Promega Corporation, Mayo Clinic Laboratories, Meridian Bioscience Inc., R-Biopharm AG, Boditech Med Inc., NanoEntek Inc., Entomogen Inc.

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

  • 2030年蚊媒傳染病檢查市場：提供新機會的國家
  • 2030年蚊媒傳染病檢查市場：充滿新機會的細分市場
  • 2030年蚊媒傳染病檢查市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第42章附錄

簡介目錄
Product Code: MM5MMREF03_G26Q2

Mosquito-borne infections testing involves identifying viruses, parasites, or bacteria transmitted by mosquitoes that cause diseases in humans. It examines clinical samples such as blood or serum to confirm infections, detect the specific pathogen, and evaluate the severity of the disease, providing essential information for timely and effective treatment as well as for implementing targeted public health measures to control outbreaks.

The primary test types of mosquito-borne infections testing include molecular diagnostic tests, serological tests, rapid antigen tests, polymerase chain reaction (PCR) testing services, and laboratory reagent-based tests. Molecular diagnostic tests refer to advanced laboratory techniques utilized to detect genetic material of pathogens responsible for mosquito-borne diseases. The different sample types include blood samples, serum samples, plasma samples, urine samples, and saliva samples, and the various infection types involved are dengue, malaria, zika virus, chikungunya, west nile virus, and other infection types. The different technologies include enzyme-linked immunosorbent assay, lateral flow assay, polymerase chain reaction, next-generation sequencing, and other technologies, and they are utilized by several end users such as hospitals and clinics, diagnostic laboratories, public health agencies, research institutes, and point-of-care settings.

Tariffs are influencing the mosquito-borne infections testing market by increasing the cost of imported diagnostic kits, molecular testing reagents, and advanced laboratory instruments used for disease detection and surveillance. This is slowing the adoption of high-precision testing technologies, particularly in import-dependent regions such as Asia-Pacific and Latin America, where healthcare systems rely heavily on global suppliers. Molecular diagnostics and PCR-based testing segments are most affected because of their dependence on semiconductor-enabled equipment and specialized reagents. However, tariffs are also encouraging domestic manufacturing of diagnostic kits, strengthening regional supply chains, and driving investment in local healthcare diagnostics ecosystems, which may improve the long-term accessibility and resilience of testing infrastructure.

The mosquito-borne infections testing market research report is one of a series of new reports from The Business Research Company that provides mosquito-borne infections testing market statistics, including mosquito-borne infections testing industry global market size, regional shares, competitors with a mosquito-borne infections testing market share, detailed mosquito-borne infections testing market segments, market trends and opportunities, and any further data you may need to thrive in the mosquito-borne infections testing industry. This mosquito-borne infections testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mosquito-borne infections testing market size has grown strongly in recent years. It will grow from $1.44 billion in 2025 to $1.56 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to increasing prevalence of dengue and malaria outbreaks, limited access to advanced diagnostic infrastructure in developing regions, growing awareness of vector-borne disease burden, expansion of laboratory testing capacity in urban healthcare systems, rising government funding for infectious disease control programs.

The mosquito-borne infections testing market size is expected to see strong growth in the next few years. It will grow to $2.12 billion by 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to climate change driven expansion of mosquito habitats and disease transmission zones, increasing adoption of rapid molecular diagnostic technologies, growth in real time outbreak monitoring and predictive surveillance systems, rising demand for integrated public health data reporting systems, expansion of personalized and precision infectious disease diagnostics. Major trends in the forecast period include rising incidence of mosquito-borne outbreaks driving demand for rapid diagnostic testing, expansion of decentralized and point-of-care testing in rural and remote regions, increasing adoption of multiplex assays for simultaneous detection of multiple vector-borne pathogens, growing government-led surveillance and screening programs for early outbreak detection, rising preference for portable and field-deployable diagnostic kits for faster epidemic response.

The increasing incidence of dengue diseases is expected to propel the growth of the mosquito borne infections testing market going forward. Dengue is a mosquito-borne viral infection caused by the dengue virus and transmitted primarily by Aedes mosquitoes. The incidence of dengue diseases is rising due to warmer temperatures and increased rainfall, which create favorable breeding conditions for Aedes mosquitoes, along with rapid urbanization that increases human exposure to mosquito populations. Mosquito-borne infections testing contributes to early detection and monitoring of dengue infections by identifying the presence of the virus in patients, thereby enabling timely medical intervention and supporting public health measures to control the spread of the disease. For instance, in July 2023, according to the World Health Organization, a Switzerland-based intergovernmental organization, Brazil documented that of the 2,376,522 dengue cases recorded up to epidemiological week 26, 1,051,773 (44.2%) were laboratory-confirmed, and 1,249 (0.05%) were classified as severe dengue, reflecting a 13% increase compared to the same period in 2022. Therefore, the increasing incidence of dengue diseases is propelling the growth of the mosquito borne infections testing market.

The increasing international travel and trade is expected to propel the growth of the mosquito borne infections testing market going forward. International travel and trade refer to the movement of people and goods across countries for purposes such as tourism, business, and global commerce. International travel and trade are expanding due to the easing of COVID-19 restrictions, which has facilitated greater global mobility for travelers and strengthened the flow of goods across international borders. International travel and trade contribute to the movement of people and goods between regions, which can introduce mosquito-borne pathogens to new geographic areas, thereby necessitating enhanced monitoring and testing for these infections to prevent potential outbreaks. For instance, in May 2024, according to the National Travel and Tourism Office (NTTO), a US-based federal government agency, total international visitor arrivals of 66.5 million in 2023 increased by 15.7 million from 50.8 million in 2022, highlighting a significant rise in global travel. Therefore, the increasing international travel and trade is propelling the growth of the mosquito borne infections testing market.

Leading companies operating in the mosquito-borne infections testing market are focusing on developing innovative methods such as automated high-throughput immunoassays to deliver faster, more accurate, and scalable detection of mosquito-borne pathogens. Automated high-throughput immunoassays are laboratory tests that automatically detect specific antigens or antibodies in large numbers of samples, helping provide rapid, accurate, and scalable diagnosis of mosquito-borne infections compared to traditional manual tests. For example, in October 2025, F. Hoffmann-La Roche Ltd., a Switzerland-based biotechnology and diagnostics company, received CE mark for its Elecsys Dengue Ag test, an innovative automated immunoassay designed to detect the NS1 antigen of the dengue virus in human serum and plasma. This test operates on Roche's fully automated cobas e analysers, providing results in just 18 minutes and reliably detecting all four dengue virus serotypes. Key features include high clinical sensitivity and specificity, medium-to-high throughput of 120-300 tests per hour, enhanced traceability, and workflow efficiency, making it particularly useful during dengue outbreaks for rapid patient management and surveillance. The Elecsys Dengue Ag test represents a significant advancement over conventional methods, delivering consistent, fast, and comprehensive diagnostic capabilities across the entire patient journey.

Major companies operating in the mosquito-borne infections testing market are F. Hoffmann-La Roche Ltd, Trinity Biotech plc, Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings (LabCorp), Grifols S. A., Hologic Inc., bioMerieux SA, Bio-Rad Laboratories Inc., QIAGEN N. V., DiaSorin S. p. A., Euroimmun Medizinische Diagnostika AG, SD Biosensor Inc., Promega Corporation, Mayo Clinic Laboratories, Meridian Bioscience Inc., R-Biopharm AG, Boditech Med Inc., NanoEntek Inc., Entomogen Inc., J. Mitra and Co. Pvt. Ltd., Today's Clinical Lab Pvt. Ltd., Co-Dx Inc.

Asia-Pacific was the largest region in the mosquito-borne infections testing market in 2025. Latin America is expected to be the fastest-growing region in the forecast period. The regions covered in the mosquito-borne infections testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the mosquito-borne infections testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mosquito-borne infections testing market consists of revenues earned by entities by providing services such as vector surveillance and mosquito population monitoring, laboratory research and outbreak management, preventive screening, outbreak tracking and reporting, and public health consultation and planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The mosquito-borne infections testing market also includes sales of serological assay kits, rapid test kits, reagents and consumables, and laboratory equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mosquito-Borne Infections Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses mosquito-borne infections testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mosquito-borne infections testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mosquito-borne infections testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Test Type: Molecular Diagnostic Tests; Serological Tests; Rapid Antigen Tests; Polymerase Chain Reaction (PCR) Testing Services; Laboratory Reagent-Based Tests
  • 2) By Sample Type: Blood Samples; Serum Samples; Plasma Samples; Urine Samples; Saliva Samples
  • 3) By Infection Type: Dengue; Malaria; Zika Virus; Chikungunya; West Nile Virus; Other Infection Types
  • 4) By Technology: Enzyme-Linked Immunosorbent Assay; Lateral Flow Assay; Polymerase Chain Reaction; Next-Generation Sequencing; Other Technologies
  • 5) By End User: Hospitals And Clinics; Diagnostic Laboratories; Public Health Agencies; Research Institutes; Point-Of-Care Settings
  • Subsegments:
  • 1) By Molecular Diagnostic Tests: Nucleic Acid Amplification Testing; Reverse Transcription Polymerase Chain Reaction Testing; Multiplex Molecular Testing; Isothermal Amplification Testing; Pathogen Specific Genetic Testing
  • 2) By Serological Tests: Immunoglobulin M Antibody Testing; Immunoglobulin G Antibody Testing; Antigen Detection Testing; Neutralization Assays; Enzyme Immunoassay Testing
  • 3) By Rapid Antigen Tests: Point Of Care Antigen Testing; Lateral Flow Antigen Testing; Immunochromatographic Antigen Testing; Portable Rapid Diagnostic Testing; Field Based Antigen Testing
  • 4) By Polymerase Chain Reaction Testing Services: Real Time Polymerase Chain Reaction Testing; Quantitative Polymerase Chain Reaction Testing; Multiplex Polymerase Chain Reaction Testing; Digital Polymerase Chain Reaction Testing; Reverse Transcription Polymerase Chain Reaction Testing
  • 5) By Laboratory Reagent Based Tests: Reagent Kit Based Diagnostic Testing; Chemical Reaction Based Testing; Enzyme Reagent Testing; Staining Reagent Testing; Buffer Solution Based Testing
  • Companies Mentioned: F. Hoffmann-La Roche Ltd; Trinity Biotech plc; Thermo Fisher Scientific Inc.; Abbott Laboratories; Laboratory Corporation of America Holdings (LabCorp); Grifols S.A.; Hologic Inc.; bioMerieux SA; Bio-Rad Laboratories Inc.; QIAGEN N.V.; DiaSorin S.p.A.; Euroimmun Medizinische Diagnostika AG; SD Biosensor Inc.; Promega Corporation; Mayo Clinic Laboratories; Meridian Bioscience Inc.; R-Biopharm AG; Boditech Med Inc.; NanoEntek Inc.; Entomogen Inc.; J. Mitra and Co. Pvt. Ltd.; Today's Clinical Lab Pvt. Ltd.; Co-Dx Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Mosquito-Borne Infections Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Mosquito-Borne Infections Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Mosquito-Borne Infections Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Mosquito-Borne Infections Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Rising Incidence Of Mosquito-Borne Outbreaks Driving Demand For Rapid Diagnostic Testing
    • 4.2.2 Expansion Of Decentralized And Point-Of-Care Testing In Rural And Remote Regions
    • 4.2.3 Increasing Adoption Of Multiplex Assays For Simultaneous Detection Of Multiple Vector-Borne Pathogens
    • 4.2.4 Growing Government-Led Surveillance And Screening Programs For Early Outbreak Detection
    • 4.2.5 Rising Preference For Portable And Field-Deployable Diagnostic Kits For Faster Epidemic Response

5. Mosquito-Borne Infections Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Diagnostic Laboratories
  • 5.3 Point-Of-Care Settings
  • 5.4 Public Health Agencies
  • 5.5 Research Institutes

6. Mosquito-Borne Infections Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Mosquito-Borne Infections Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Mosquito-Borne Infections Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Mosquito-Borne Infections Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Mosquito-Borne Infections Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Mosquito-Borne Infections Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Mosquito-Borne Infections Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Mosquito-Borne Infections Testing Market Segmentation

  • 9.1. Global Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Molecular Diagnostic Tests, Serological Tests, Rapid Antigen Tests, Polymerase Chain Reaction (PCR) Testing Services, Laboratory Reagent-Based Tests
  • 9.2. Global Mosquito-Borne Infections Testing Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood Samples, Serum Samples, Plasma Samples, Urine Samples, Saliva Samples
  • 9.3. Global Mosquito-Borne Infections Testing Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Dengue, Malaria, Zika Virus, Chikungunya, West Nile Virus, Other Infection Types
  • 9.4. Global Mosquito-Borne Infections Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Enzyme-Linked Immunosorbent Assay, Lateral Flow Assay, Polymerase Chain Reaction, Next-Generation Sequencing, Other Technologies
  • 9.5. Global Mosquito-Borne Infections Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Diagnostic Laboratories, Public Health Agencies, Research Institutes, Point-Of-Care Settings
  • 9.6. Global Mosquito-Borne Infections Testing Market, Sub-Segmentation Of Molecular Diagnostic Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Nucleic Acid Amplification Testing, Reverse Transcription Polymerase Chain Reaction Testing, Multiplex Molecular Testing, Isothermal Amplification Testing, Pathogen Specific Genetic Testing
  • 9.7. Global Mosquito-Borne Infections Testing Market, Sub-Segmentation Of Serological Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Immunoglobulin M Antibody Testing, Immunoglobulin G Antibody Testing, Antigen Detection Testing, Neutralization Assays, Enzyme Immunoassay Testing
  • 9.8. Global Mosquito-Borne Infections Testing Market, Sub-Segmentation Of Rapid Antigen Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Point Of Care Antigen Testing, Lateral Flow Antigen Testing, Immunochromatographic Antigen Testing, Portable Rapid Diagnostic Testing, Field Based Antigen Testing
  • 9.9. Global Mosquito-Borne Infections Testing Market, Sub-Segmentation Of Polymerase Chain Reaction Testing Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Real Time Polymerase Chain Reaction Testing, Quantitative Polymerase Chain Reaction Testing, Multiplex Polymerase Chain Reaction Testing, Digital Polymerase Chain Reaction Testing, Reverse Transcription Polymerase Chain Reaction Testing
  • 9.10. Global Mosquito-Borne Infections Testing Market, Sub-Segmentation Of Laboratory Reagent Based Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Reagent Kit Based Diagnostic Testing, Chemical Reaction Based Testing, Enzyme Reagent Testing, Staining Reagent Testing, Buffer Solution Based Testing

10. Mosquito-Borne Infections Testing Market Regional And Country Analysis

  • 10.1. Global Mosquito-Borne Infections Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Mosquito-Borne Infections Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Mosquito-Borne Infections Testing Market

  • 11.1. Asia-Pacific Mosquito-Borne Infections Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Mosquito-Borne Infections Testing Market

  • 12.1. China Mosquito-Borne Infections Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Mosquito-Borne Infections Testing Market

  • 13.1. India Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Mosquito-Borne Infections Testing Market

  • 14.1. Japan Mosquito-Borne Infections Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Mosquito-Borne Infections Testing Market

  • 15.1. Australia Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Mosquito-Borne Infections Testing Market

  • 16.1. Indonesia Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Mosquito-Borne Infections Testing Market

  • 17.1. South Korea Mosquito-Borne Infections Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Mosquito-Borne Infections Testing Market

  • 18.1. Taiwan Mosquito-Borne Infections Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Mosquito-Borne Infections Testing Market

  • 19.1. South East Asia Mosquito-Borne Infections Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Mosquito-Borne Infections Testing Market

  • 20.1. Western Europe Mosquito-Borne Infections Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Mosquito-Borne Infections Testing Market

  • 21.1. UK Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Mosquito-Borne Infections Testing Market

  • 22.1. Germany Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Mosquito-Borne Infections Testing Market

  • 23.1. France Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Mosquito-Borne Infections Testing Market

  • 24.1. Italy Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Mosquito-Borne Infections Testing Market

  • 25.1. Spain Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Mosquito-Borne Infections Testing Market

  • 26.1. Eastern Europe Mosquito-Borne Infections Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Mosquito-Borne Infections Testing Market

  • 27.1. Russia Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Mosquito-Borne Infections Testing Market

  • 28.1. North America Mosquito-Borne Infections Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Mosquito-Borne Infections Testing Market

  • 29.1. USA Mosquito-Borne Infections Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Mosquito-Borne Infections Testing Market

  • 30.1. Canada Mosquito-Borne Infections Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Mosquito-Borne Infections Testing Market

  • 31.1. South America Mosquito-Borne Infections Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Mosquito-Borne Infections Testing Market

  • 32.1. Brazil Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Mosquito-Borne Infections Testing Market

  • 33.1. Middle East Mosquito-Borne Infections Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Mosquito-Borne Infections Testing Market

  • 34.1. Africa Mosquito-Borne Infections Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Mosquito-Borne Infections Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Mosquito-Borne Infections Testing Market Regulatory and Investment Landscape

36. Mosquito-Borne Infections Testing Market Competitive Landscape And Company Profiles

  • 36.1. Mosquito-Borne Infections Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Mosquito-Borne Infections Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Mosquito-Borne Infections Testing Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Trinity Biotech plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Laboratory Corporation of America Holdings (LabCorp) Overview, Products and Services, Strategy and Financial Analysis

37. Mosquito-Borne Infections Testing Market Other Major And Innovative Companies

  • Grifols S.A., Hologic Inc., bioMerieux SA, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Euroimmun Medizinische Diagnostika AG, SD Biosensor Inc., Promega Corporation, Mayo Clinic Laboratories, Meridian Bioscience Inc., R-Biopharm AG, Boditech Med Inc., NanoEntek Inc., Entomogen Inc.

38. Global Mosquito-Borne Infections Testing Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Mosquito-Borne Infections Testing Market

41. Mosquito-Borne Infections Testing Market High Potential Countries, Segments and Strategies

  • 41.1 Mosquito-Borne Infections Testing Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Mosquito-Borne Infections Testing Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Mosquito-Borne Infections Testing Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer